| Human CXCL16 Protein (LTP10318) |
| LTP10318 |
| 100ug |
|
$450 In stock |
| CXC chemokine ligand 16 (CXCL16) is a CXC soluble chemokine, an adhesion molecule and a cell surface scavenger receptor. CXCL16 regulates inflammation, tissue injury and fibrosis. Parenchymal renal cells, vascular wall cells, leukocytes and platelets express and/or release CXCL16 under the regulation of inflammatory mediators. CXCL16 expression is increased in experimental and human nephropathies. Targeting CXCL16 protected from experimental glomerular injury or interstitial fibrosis. |
| Recombinant Human CXCL16 Protein is expressed from Expi293 with hFc tag at the C-terminal. It contains Asn30-Thr205. |
| CXCL16 |
| Human |
| Q9H2A7 |
| Asn30-Thr205 |
| The protein has a predicted MW of 45.9 kDa. Due to glycosylation, the protein migrates to 70-75 kDa based on the Tris-Bis PAGE result. |
| 0 |
| C-hFc |
| Expi293 |
| > 95% as determined by Tris-Bis PAGE |
| Less than 1EU per ug by the LAL method. |
| Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as a protectant before lyophilization. |
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
| Shipped at ambient temperature. |
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
| |